SCHEMBL6624890

SCHEMBL6624890

CSc1nc(Cl)c(-c2ccccc2)c(Oc2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 4/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
HTT P42858 6/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 2/20 0.45
KDR P35968 2/20 0.45
ESR1 P03372 2/20 0.42
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NPC1 O15118 1/20 0.40
XBP1 P17861 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4844072 0.84 KDM4E (0.49) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL6629638 0.81 MAPT (0.57) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2876019 0.76 HSP90AA1 (0.50) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2876016 0.76 KDM4E (0.43) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL13064595 0.75 DHFR (0.47) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL13020880 0.74 KDM4E (0.41) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL4839488 0.73 KDM4E (0.57) MAPTL3MBTL1ALDH1A1KDM4ECYP1A2
SCHEMBL10847225 0.73 HSP90AA1 (0.43) MAPTKDM4EHTTMEN1KMT2A
SCHEMBL7699598 0.70 KDM4E (0.49) MAPTL3MBTL1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL6623348 0.69 MEN1 (0.69) MAPTL3MBTL1ALDH1A1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0976753-B1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES KYOWA HAKKO KOGYO KK (JP) 2004-01-02 EP disclosed
US-6222035-B1 AS ADENOSINE A.SUB.2A RECEPTOR ANTAGONISTS AND ARE USEFUL FOR THERAPY OR OR PROPHYLAXIS OF VARIOUS DISEASES INDUCED BY HYPERACTIVITY OF ADENOSINE A.SUB.2A RECEPTORS SUCH AS PARKINSON'S DISEASE, SENILE DEMENTIA OR DEPRESSION KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-04-24 US disclosed
EP-0976753-A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 2000-02-02 EP disclosed